References
Hacke W, Albers G, Bogousslavsky J, et al.: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66–73.
Furlan AJ, Eyding D, Albers GW, et al.: Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37:1227–1231.
Kidwell CS, Alger JR, Saver JL: Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 2004, 35(Suppl 1):2662–2665.
Warach S: Measurement of the ischemic penumbra with MRI: it’s about time. Stroke 2003, 34:2533–2534.
Albers GW, Thijs VN, Wechsler L, et al.: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) Study. Ann Neurol 2006, 60:508–517.
Rights and permissions
About this article
Cite this article
Adams, H.P. Extending the time frame for emergency intravenous thrombolytic therapy for treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 9, 3–5 (2009). https://doi.org/10.1007/s11910-009-0001-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11910-009-0001-1